Psychiatry & Neurology Doctors in Lewistown, PA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Abigail Elizabeth Cummings, PA-C Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 6 N Dorcas St, Lewistown, PA 17044 Phone: 717-953-0571    Fax: 717-053-0576

Dr. Nitin Vasantrai Sheth, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 6 N Dorcas St, Lewistown, PA 17044 Phone: 717-953-9571    Fax: 717-953-9576

Dr. Raymond A Johnson, M.D. Psychiatry & Neurology - Addiction Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 134 W Market St, Lewistown, PA 17044 Phone: 717-437-9000    Fax: 717-437-9001

Nalin Gordhanbhai Patel, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 134 W Market St, Lewistown, PA 17044 Phone: 717-242-7145    Fax: 717-437-9001

News Archive

Spanish doctors perform more than 1,500 POSE weight loss procedures

Spanish doctors are leading the way by performing more than 1,500 procedures of the scar-free, non invasive, weight loss method of Primary Obesity Surgery, Endolumenal, known as POSE. Over thirty Spanish doctors have now performed more cases in Spain (where 1 in 6 people are obese) than in any other part of the world.

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.

SGC and CHDI Foundation collaborate to discover new drug targets for Huntington's disease

The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.

Clinical trial of 5 day treatment for earliest form of breast cancer

Researchers at Virginia Commonwealth University's Massey Cancer Center have begun a clinical trial testing the effectiveness of an established balloon catheter radiation delivery device on the earliest form of breast cancer, ductal carcinoma in situ.

Read more Medical News

› Verified 2 days ago